Skip to content
Open access

CMR feature-tracking derived left atrial late diastolic strain rate is associated with long-term outcomes in non-ischemic heart failure patients with severely reduced LVEF

Sep 2026 · BMC Cardiovascular Disorders · 0 citations

Abstract

Heart failure (HF) patients with LVEF ≤ 35% remain at high risk of adverse outcomes. Cardiac magnetic resonance (CMR) feature-tracking (FT) enable the assessment of left atrial (LA) deformation, but the long-term prognostic value of LA strain parameters in this high-risk population remains unclear. This study evaluated whether CMR-derived LA strain and strain-rate parameters are associated with long-term outcomes in HF patients with LVEF ≤ 35%. This retrospective study included 214 consecutive patients with non-ischemic HF and LVEF ≤ 35% who underwent CMR between March 2018 and December 2020. Conventional CMR parameters and FT derived strain parameters were assessed. The primary endpoint was a composite of all-cause death or heart transplantation. The secondary endpoint was unplanned hospitalization for worsening heart failure. Cox proportional hazards models, Kaplan-Meier survival analysis, and model discrimination assessed by C-index were used to evaluate the prognostic value of LA strain parameters. During a median follow-up interval of 61 months (IQR, 52 - 68.25), 32 patients reached the primary endpoint and 96 patients reached the secondary endpoint. After adjustment for clinical and CMR parameters, SRa remained associated with the primary endpoint [hazard ratio (HR), 2.761; 95% confidence intervals (CI), 1.120 - 6.804; P = 0.027] and the secondary endpoint (HR, 1.862; 95% CI, 1.163 - 2.981; P = 0.010). Hemoglobin and LV end-diastolic volume index (LVEDVi) were additionally associated with the primary endpoint, while atrial fibrillation history and LVEDVi were associated with the secondary endpoint. In HF patients with LVEF ≤ 35%, CMR-FT derived SRa was associated with the risks of all-cause death or heart transplantation and heart failure worsening hospitalization. SRa may serve as a potential complementary prognostic marker in severe LV systolic dysfunction.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.